Technology

Affirm plans to bring Buy Now, Pay Later debit cards to...

Affirm is working with fintech company FIS to bring its debit card to more banks.

Sam Altman says Musk aims to 'slow down a competitor' w...

Elon Musk is leading a group of investors in offering to buy control of OpenAI f...

Musk's $97.4-billion bid for OpenAI aims to 'slow down ...

Elon Musk is leading a group of investors in offering to buy control of OpenAI f...

EU says AI race 'far from over' as bloc pledges 50-bill...

Speaking at the AI Action Summit in Paris, European Commission President Ursula ...

Musk's $97.4 billion bid for OpenAI aims to 'slow down ...

Elon Musk is leading a group of investors in offering to buy control of OpenAI f...

JD Vance says U.S. will defend American AI and block ef...

Vice President JD Vance said the U.S. will safeguard American artificial intelli...

Google Calendar no longer includes start of Black Histo...

Google Calendar has removed reference to observances like the beginning of Black...

Eight years after selling AppDynamics to Cisco, Jyoti B...

Jyoti Bansal, who sold AppDynamics to Cisco for $3.7 billion, is pulling togethe...

DeepSeek’s AI model is ‘the best work’ out of China but...

DeepSeek's AI model "is probably the best work" out of China, Demis Hassabis sai...

DeepSeek’s AI model is ‘the best work’ out of China but...

DeepSeek's AI model "is probably the best work" out of China, Demis Hassabis sai...

France unveils 109-billion-euro AI investment as Europe...

Macron announced the mammoth investment sum ahead of France's AI Action Summit, ...

Deepseek’s AI model is ‘the best work’ out of China but...

Deepseek's AI model "is probably the best work" out of China, Demis Hassabis sai...

Anduril in talks to raise money at $28 billion valuatio...

Anduril has signed a term sheet to raise up to $2.5 billion at a valuation of $2...

Hims & Hers faces scrutiny from senators on Super Bowl ...

Two U.S. senators wrote a letter to the Food and Drug Administration on Friday e...

Doximity shares pop 36% on revenue beat, rosy guidance

The company built a digital platform for medical professionals that can help the...

Hims & Hers faces scrutiny from lawmakers over 'mislead...

Two U.S. senators wrote a letter to the Food and Drug Administration on Friday e...